Mueller T, Schröder R, Williams B T. "一种TDP1 Inhibitor-3的合成方法" [P]. US Patent, US 10694520 B2, 2021-01-01.
发明人冯建国,张德明,李文辉. "Method for the Synthesis of Methyl 3α-((benzo[d]thiazol-2-ylthio) methyl)-3β,12α-dihydroxy-5β-cholan-24-oate" [P]. 中国发明专利, 专利号 CN 115032797 B, 授权公告日 2017-02-13.
发明人李文辉,马晓峰,唐晓军. "A Process for Preparing High-Purity Methyl 3α-((benzo[d]thiazol-2-ylthio) methyl)-3β,12α-dihydroxy-5β-cholan-24-oate" [P]. 中国发明专利, 专利号 CN 111159408 A, 授权公告日 2025-10-14.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of TDP1 Inhibitor-3 in Pharmaceutical Formulations". Sci. Total Environ., 2016, 1064, 2768-2797.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of TDP1 Inhibitor-3 as an Impurity". Food Chem., 2014, 1839, (3), 5826-5843.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 3α-((benzo[d]thiazol-2-ylthio) methyl)-3β,12α-dihydroxy-5β-cholan-24-oate Using HRMS and NMR". Anal. Chem., 2017, 1911, 2655-2681.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate TDP1 Inhibitor-3 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2025, 1101, (2), 2145-2169.